Australia — Therapeutic Goods Administration
Tracked across 3 events · 26 articles · First seen May 05, 2026 · Last active Jun 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The Australia — Therapeutic Goods Administration granted approval for 4DMedical Limited's CT:VQ technology, allowing its commercial deployment in Australia. This regulatory body's decision is crucial for market access.
Jun 29, 2026 · 8 articles
Business
Impact: The Australia — Therapeutic Goods Administration in Australia oversees the Authorized Prescriber Scheme, under which Optimi Health's psilocybin is prescribed and reimbursed, facilitating patient access to psychedelic medicine.
Jun 29, 2026 · 12 articles
100
Australia — Therapeutic Goods Administration granted approval 4DMedical Limited4DMedical CT:VQ TGA...
ERGEN INTELLIGENCE
Track Australia — Therapeutic Goods Administration live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard